Cargando…
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253107/ https://www.ncbi.nlm.nih.gov/pubmed/37296815 http://dx.doi.org/10.3390/diagnostics13111963 |
_version_ | 1785056328526331904 |
---|---|
author | Reinert, Christian Philipp Liang, Cecilia Weissinger, Matthias Vogel, Jonas Forschner, Andrea Nikolaou, Konstantin la Fougère, Christian Seith, Ferdinand |
author_facet | Reinert, Christian Philipp Liang, Cecilia Weissinger, Matthias Vogel, Jonas Forschner, Andrea Nikolaou, Konstantin la Fougère, Christian Seith, Ferdinand |
author_sort | Reinert, Christian Philipp |
collection | PubMed |
description | Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT) with (18)F-FDG positron emission tomography (PET)/CT and (18)F-PET/MRI together with a follow-up as the reference standard. Methods: Between April 2014 and April 2018, a total of 57 patients (25 females, mean age of 64 ± 12 years) underwent WB-PET/CT and WB-PET/MRI on the same day. The CT and MRI scans were independently evaluated by two radiologists who were blinded to the patients’ information. The reference standard was evaluated by two nuclear medicine specialists. The findings were categorized into different regions: lymph nodes/soft tissue (I), lungs (II), abdomen/pelvis (III), and bone (IV). A comparative analysis was conducted for all the documented findings. Inter-reader reliability was assessed using Bland–Altman procedures, and McNemar’s test was utilized to determine the differences between the readers and the methods. Results: Out of the 57 patients, 50 were diagnosed with metastases in two or more regions, with the majority being found in region I. The accuracies of CT and MRI did not show significant differences, except in region II where CT detected more metastases compared to MRI (0.90 vs. 0.68, p = 0.008). On the other hand, MRI had a higher detection rate in region IV compared to CT (0.89 vs. 0.61, p > 0.05). The level of agreement between the readers varied depending on the number of metastases and the specific region, with the highest agreement observed in region III and the lowest observed in region I. Conclusions: In patients with advanced melanoma, WB-MRI has the potential to serve as an alternative to CT with comparable diagnostic accuracy and confidence across most regions. The observed limited sensitivity for the detection of pulmonary lesions might be improved through dedicated lung imaging sequences. |
format | Online Article Text |
id | pubmed-10253107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102531072023-06-10 Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study Reinert, Christian Philipp Liang, Cecilia Weissinger, Matthias Vogel, Jonas Forschner, Andrea Nikolaou, Konstantin la Fougère, Christian Seith, Ferdinand Diagnostics (Basel) Article Purpose: The consideration of radiation exposure is becoming more important in metastatic melanoma due to improved prognoses. The aim of this prospective study was to investigate the diagnostic performance of whole-body (WB) magnetic resonance imaging (MRI) in comparison to computed tomography (CT) with (18)F-FDG positron emission tomography (PET)/CT and (18)F-PET/MRI together with a follow-up as the reference standard. Methods: Between April 2014 and April 2018, a total of 57 patients (25 females, mean age of 64 ± 12 years) underwent WB-PET/CT and WB-PET/MRI on the same day. The CT and MRI scans were independently evaluated by two radiologists who were blinded to the patients’ information. The reference standard was evaluated by two nuclear medicine specialists. The findings were categorized into different regions: lymph nodes/soft tissue (I), lungs (II), abdomen/pelvis (III), and bone (IV). A comparative analysis was conducted for all the documented findings. Inter-reader reliability was assessed using Bland–Altman procedures, and McNemar’s test was utilized to determine the differences between the readers and the methods. Results: Out of the 57 patients, 50 were diagnosed with metastases in two or more regions, with the majority being found in region I. The accuracies of CT and MRI did not show significant differences, except in region II where CT detected more metastases compared to MRI (0.90 vs. 0.68, p = 0.008). On the other hand, MRI had a higher detection rate in region IV compared to CT (0.89 vs. 0.61, p > 0.05). The level of agreement between the readers varied depending on the number of metastases and the specific region, with the highest agreement observed in region III and the lowest observed in region I. Conclusions: In patients with advanced melanoma, WB-MRI has the potential to serve as an alternative to CT with comparable diagnostic accuracy and confidence across most regions. The observed limited sensitivity for the detection of pulmonary lesions might be improved through dedicated lung imaging sequences. MDPI 2023-06-05 /pmc/articles/PMC10253107/ /pubmed/37296815 http://dx.doi.org/10.3390/diagnostics13111963 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reinert, Christian Philipp Liang, Cecilia Weissinger, Matthias Vogel, Jonas Forschner, Andrea Nikolaou, Konstantin la Fougère, Christian Seith, Ferdinand Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title | Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title_full | Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title_fullStr | Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title_full_unstemmed | Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title_short | Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study |
title_sort | whole-body magnetic resonance imaging (mri) for staging melanoma patients in direct comparison to computed tomography (ct): results from a prospective positron emission tomography (pet)/ct and pet/mri study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253107/ https://www.ncbi.nlm.nih.gov/pubmed/37296815 http://dx.doi.org/10.3390/diagnostics13111963 |
work_keys_str_mv | AT reinertchristianphilipp wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT liangcecilia wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT weissingermatthias wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT vogeljonas wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT forschnerandrea wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT nikolaoukonstantin wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT lafougerechristian wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy AT seithferdinand wholebodymagneticresonanceimagingmriforstagingmelanomapatientsindirectcomparisontocomputedtomographyctresultsfromaprospectivepositronemissiontomographypetctandpetmristudy |